Latest news with #LeonidCapitalPartners
Business Wire
7 days ago
- Business
- Business Wire
Leonid Capital Partners Taps STATION DC to Launch Washington Headquarters, Accelerate Defense-Tech Investment
WASHINGTON, D.C.--(BUSINESS WIRE)--Leonid Capital Partners, the Orange County, CA.-based Trusted Capital Partner to the U.S. Department of Defense, today announced a partnership with STATION DC, the nonprofit tech incubator and members club where frontier-tech founders, investors, military leaders, and policymakers meet. By anchoring its first permanent District office inside STATION DC's Union Market clubhouse, Leonid will accelerate local investment, job creation, and policy engagement—delivering on the spirit of the city's focus on attracting the tech sector, including Mayor Muriel Bowser's Growth Agenda and Tech Ecosystem Fund, which are now before the D.C. Council. 'Washington is where policy meets possibility—exactly where Leonid needs to be,' said James Parker, Co-Founding Partner of Leonid Capital Partners. 'Partnering with STATION DC lets us plant our flag in the capital, expand our checkbook for D.C. innovators, and give defense-tech founders a turnkey gateway to the relationships that move the needle. We're committed to financing more companies here, supporting the local talent pipeline, and helping keep America competitive.' 'The proposed Tech Ecosystem Fund was designed to help spark partnerships just like this that attract world-class investors to DC,' said James Barlia, Executive Director of STATION DC. 'Leonid's capital and operating know-how—paired with our network, programming, and convening power—will shrink the distance between a founder's prototype and a Pentagon contract while keeping the economic upside and jobs right here in the District.' Partnership Highlights: Establishing Leonid's first permanent D.C. workspace inside STATION DC's Union Market clubhouse—providing proximity to policymakers and federal buyers. Increasing capital investment in the region's growing defense and dual-use innovation ecosystem. Co-hosting private salons, roundtables, and strategic convenings with founders, government leaders, and investors focused on accelerating innovation tied to national purpose. Providing mentorship and community support to STATION DC members, including early-stage founders navigating the complexities of federal contracting and scale. These benefits are designed to scale with additional corporate partners and to showcase how programs like the Tech Ecosystem Fund, the District's proposed $2.4 million investment in business accelerators and incubators for start-up tech companies in DC, can unlock a surge of private capital, world-class talent, cross-sector partnerships, and mission-driven innovation—cementing D.C. as the front door for America's tech competitiveness future. About Leonid Capital Partners Leonid Capital Partners is a leading provider of flexible, non-dilutive investments for venture-backed defense and dual-use technology companies. By pairing deep government-contracting expertise with tailored capital solutions, Leonid accelerates growth for founders advancing U.S. national security. STATION DC is a nonprofit members club and convening space accelerating American innovation at the intersection of technology, policy, and capital. Located in Union Market, STATION DC hosts salons, summits, and working sessions that strengthen the nation's competitive edge.
Yahoo
27-01-2025
- Business
- Yahoo
Anivive Secures $20 Million Investment from Leonid Capital Partners to Develop the Next Generation of Pet Health
Funding expands manufacturing readiness for Valley fever vaccine This follows Anivive's $33MM NIAID contract for fungal vaccines In total, Anivive has secured over $80MM in contracts and preorders LONG BEACH, Calif., Jan. 27, 2025 /PRNewswire/ -- Anivive Lifesciences, a software-driven pet health company, is pleased to announce it has secured $20MM in funding from Leonid Capital Partners ("Leonid"). Leonid is a leading investment firm focused on high-growth technology companies working in the national security industry. "Anivive's vision to improve and extend the lives of pets aligns perfectly with our mission to empower companies driving meaningful innovation," said Chris Lay, Co-Founder of Leonid Capital Partners. "We're excited to support their groundbreaking work, which has the potential to transform veterinary care for millions of pets and their families." The $20MM investment will help Anivive bolster its research programs, expand its manufacturing capabilities, and drive commercialization of its canine vaccine for Valley fever, the first-ever antifungal vaccine. Anivive's direct-to-veterinarian sales platform Engage launched in early 2024 and has already processed over 9,000 orders. This investment comes on the heels of Anivive's recent $33M contract with the National Institutes of Health to support the development of a human vaccine against the fungus Coccidioides, which causes Valley fever. Across its pipeline, Anivive now has $80MM in preorders and commitments from industry partners. "This partnership with Leonid is a significant milestone for Anivive," said Dylan Balsz, CEO of Anivive. "Their capital allows us to focus on what we do best – developing cutting-edge treatments that will change the way we care for our pets." Anivive uses technology driven strategies to create novel, affordable healthcare solutions for pets. Through a proprietary AI platform, Anivive accelerates drug discovery and development by repurposing human treatments for veterinary use. It focuses on tackling life-threatening diseases like pet cancer, feline infectious peritonitis, systemic fungal diseases, and other emerging illnesses. About Anivive Lifesciences Anivive Lifesciences is a pet pharmaceutical company at the forefront of biotechnology, artificial intelligence, and veterinary medicine. Our mission is to transform veterinary healthcare by accelerating the development of novel, affordable treatments for life-threatening diseases in pets. Through our proprietary AI platform, we are pioneering first-in-class therapeutics in Oncology, Antivirals, and Antifungal Vaccines, setting new standards for innovation and excellence in the industry. To learn more, visit About Leonid Capital Partners Leonid Capital Partners invests capital into critical national security initiatives. The firm leverages its deep government and technical expertise to provide its portfolio companies with the flexible resources they need to grow their business. Learn more at View original content to download multimedia: SOURCE Anivive Lifesciences Inc. Sign in to access your portfolio
